vs

Side-by-side financial comparison of Snail, Inc. (SNAL) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.

ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $25.1M, roughly 1.1× Snail, Inc.). Snail, Inc. runs the higher net margin — -3.4% vs -147.1%, a 143.7% gap on every dollar of revenue. On growth, Snail, Inc. posted the faster year-over-year revenue change (-4.2% vs -67.6%).

Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....

ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.

SNAL vs SPRY — Head-to-Head

Bigger by revenue
SPRY
SPRY
1.1× larger
SPRY
$28.1M
$25.1M
SNAL
Growing faster (revenue YoY)
SNAL
SNAL
+63.3% gap
SNAL
-4.2%
-67.6%
SPRY
Higher net margin
SNAL
SNAL
143.7% more per $
SNAL
-3.4%
-147.1%
SPRY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SNAL
SNAL
SPRY
SPRY
Revenue
$25.1M
$28.1M
Net Profit
$-862.2K
$-41.3M
Gross Margin
38.3%
Operating Margin
-6.0%
-147.6%
Net Margin
-3.4%
-147.1%
Revenue YoY
-4.2%
-67.6%
Net Profit YoY
-177.0%
-182.8%
EPS (diluted)
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SNAL
SNAL
SPRY
SPRY
Q4 25
$25.1M
$28.1M
Q3 25
$13.8M
$32.5M
Q2 25
$22.2M
$15.7M
Q1 25
$20.1M
$8.0M
Q4 24
$26.2M
$86.6M
Q3 24
$22.5M
$2.1M
Q2 24
$21.6M
$500.0K
Q1 24
$14.1M
$0
Net Profit
SNAL
SNAL
SPRY
SPRY
Q4 25
$-862.2K
$-41.3M
Q3 25
$-7.9M
$-51.2M
Q2 25
$-16.6M
$-44.9M
Q1 25
$-1.9M
$-33.9M
Q4 24
$1.1M
$49.9M
Q3 24
$235.1K
$-19.1M
Q2 24
$2.3M
$-12.5M
Q1 24
$-1.8M
$-10.3M
Gross Margin
SNAL
SNAL
SPRY
SPRY
Q4 25
38.3%
Q3 25
0.1%
Q2 25
31.3%
Q1 25
29.1%
Q4 24
43.3%
Q3 24
38.6%
Q2 24
37.5%
Q1 24
14.7%
Operating Margin
SNAL
SNAL
SPRY
SPRY
Q4 25
-6.0%
-147.6%
Q3 25
-71.3%
-163.7%
Q2 25
-8.2%
-302.9%
Q1 25
-20.4%
-466.3%
Q4 24
11.5%
54.5%
Q3 24
1.8%
-1051.6%
Q2 24
12.4%
-3068.0%
Q1 24
-15.6%
Net Margin
SNAL
SNAL
SPRY
SPRY
Q4 25
-3.4%
-147.1%
Q3 25
-56.9%
-157.4%
Q2 25
-74.7%
-285.6%
Q1 25
-9.7%
-425.7%
Q4 24
4.3%
57.7%
Q3 24
1.0%
-925.0%
Q2 24
10.4%
-2503.2%
Q1 24
-12.6%
EPS (diluted)
SNAL
SNAL
SPRY
SPRY
Q4 25
$-0.41
Q3 25
$-0.52
Q2 25
$-0.44
$-0.46
Q1 25
$-0.06
$-0.35
Q4 24
$0.03
$0.52
Q3 24
$0.01
$-0.20
Q2 24
$0.06
$-0.13
Q1 24
$-0.05
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SNAL
SNAL
SPRY
SPRY
Cash + ST InvestmentsLiquidity on hand
$8.6M
$245.0M
Total DebtLower is stronger
$14.6M
$96.4M
Stockholders' EquityBook value
$-16.4M
$114.3M
Total Assets
$59.3M
$327.7M
Debt / EquityLower = less leverage
0.84×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SNAL
SNAL
SPRY
SPRY
Q4 25
$8.6M
$245.0M
Q3 25
$12.3M
$288.2M
Q2 25
$7.9M
$240.1M
Q1 25
$9.4M
$275.7M
Q4 24
$7.3M
$314.0M
Q3 24
$10.6M
$204.6M
Q2 24
$15.5M
$218.7M
Q1 24
$16.1M
$223.6M
Total Debt
SNAL
SNAL
SPRY
SPRY
Q4 25
$14.6M
$96.4M
Q3 25
$10.5M
$96.2M
Q2 25
$11.8M
Q1 25
$9.0M
Q4 24
$5.7M
$0
Q3 24
$5.7M
Q2 24
$5.8M
Q1 24
$6.5M
Stockholders' Equity
SNAL
SNAL
SPRY
SPRY
Q4 25
$-16.4M
$114.3M
Q3 25
$-15.6M
$147.7M
Q2 25
$-8.0M
$192.3M
Q1 25
$9.1M
$229.0M
Q4 24
$9.7M
$256.8M
Q3 24
$8.2M
$201.0M
Q2 24
$7.9M
$215.2M
Q1 24
$5.6M
$223.9M
Total Assets
SNAL
SNAL
SPRY
SPRY
Q4 25
$59.3M
$327.7M
Q3 25
$51.1M
$372.8M
Q2 25
$58.0M
$313.5M
Q1 25
$64.5M
$327.3M
Q4 24
$62.2M
$351.2M
Q3 24
$66.8M
$217.6M
Q2 24
$75.4M
$222.0M
Q1 24
$78.3M
$227.6M
Debt / Equity
SNAL
SNAL
SPRY
SPRY
Q4 25
0.84×
Q3 25
0.65×
Q2 25
Q1 25
0.99×
Q4 24
0.59×
0.00×
Q3 24
0.70×
Q2 24
0.73×
Q1 24
1.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SNAL
SNAL
SPRY
SPRY
Operating Cash FlowLast quarter
$-5.3M
$-43.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SNAL
SNAL
SPRY
SPRY
Q4 25
$-5.3M
$-43.5M
Q3 25
$6.6M
$-47.0M
Q2 25
$-3.2M
$-39.6M
Q1 25
$764.5K
$-40.7M
Q4 24
$-3.6M
$42.0M
Q3 24
$-5.0M
$-14.5M
Q2 24
$206.6K
$-7.3M
Q1 24
$6.8M
$-6.7M
Free Cash Flow
SNAL
SNAL
SPRY
SPRY
Q4 25
Q3 25
$-47.2M
Q2 25
$-39.6M
Q1 25
$-40.8M
Q4 24
$41.7M
Q3 24
$-14.6M
Q2 24
$-7.3M
Q1 24
$-6.8M
FCF Margin
SNAL
SNAL
SPRY
SPRY
Q4 25
Q3 25
-145.4%
Q2 25
-252.2%
Q1 25
-512.1%
Q4 24
48.2%
Q3 24
-706.3%
Q2 24
-1463.4%
Q1 24
Capex Intensity
SNAL
SNAL
SPRY
SPRY
Q4 25
0.0%
Q3 25
0.6%
Q2 25
0.3%
Q1 25
1.1%
Q4 24
0.3%
Q3 24
6.8%
Q2 24
7.6%
Q1 24
Cash Conversion
SNAL
SNAL
SPRY
SPRY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-3.21×
0.84×
Q3 24
-21.05×
Q2 24
0.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SNAL
SNAL

Pc$14.7M59%
Platform Three$5.2M21%
Platform Two$3.3M13%
Sales Channel Directly To Consumer Mobile Sale$1.6M6%

SPRY
SPRY

Products$20.3M72%
Other$7.8M28%

Related Comparisons